BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17761039)

  • 21. Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus.
    Davenport C; Liew A; Vic Lau P; Smith D; Thompson CJ; Kearns G; Agha A
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):86-9. PubMed ID: 19940203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypernatraemia in critically ill patients: too little water and too much salt.
    Hoorn EJ; Betjes MG; Weigel J; Zietse R
    Nephrol Dial Transplant; 2008 May; 23(5):1562-8. PubMed ID: 18065827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polyuria and polydipsia due to renal diabetes insipidus during the use of lithium].
    van Gerven HA; Boer WH
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1705-9. PubMed ID: 16924939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypernatremia in the acutely ill elderly patients: role of impaired arginine-vasopressin secretion.
    Sonnenblick M; Algur N
    Miner Electrolyte Metab; 1993; 19(1):32-5. PubMed ID: 8345832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential hypernatremia: disordered thirst and blood pressure control.
    Brown MA; Mullins R; Stokes GS; Györy AZ
    Aust N Z J Med; 1985 Dec; 15(6):751-4. PubMed ID: 3869442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
    Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
    Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of sodium depletion in acute antidiuretic effect of bendroflumethiazide in rats with nephrogenic diabetes insipidus.
    Janjua NR; Jonassen TE; Langhoff S; Thomsen K; Christensen S
    J Pharmacol Exp Ther; 2001 Oct; 299(1):307-13. PubMed ID: 11561093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
    Guirguis AF; Taylor HC
    Endocr Pract; 2000; 6(4):324-8. PubMed ID: 11242610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperosmolar nonketotic coma precipitated by lithium-induced nephrogenic diabetes insipidus.
    Azam H; Newton RW; Morris AD; Thompson CJ
    Postgrad Med J; 1998 Jan; 74(867):39-41. PubMed ID: 9538487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
    Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic renal function disorders during lithium use].
    van Gerven HA; Boer WH
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1715-8. PubMed ID: 16924942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complications during lithium maintenance therapy].
    Di Paolo A
    Rev Med Brux; 2005; 26(3):173-7. PubMed ID: 16038143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypernatraemia due to a reset osmostat for vasopressin release and thirst, complicated by nephrogenic diabetes insipidus.
    Thompson CJ; Freeman J; Record CO; Baylis PH
    Postgrad Med J; 1987 Nov; 63(745):979-82. PubMed ID: 3451225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
    Non L; Brito D; Anastasopoulou C
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion.
    Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2006 Aug; 176(2):749-53. PubMed ID: 16813935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes insipidus: clinical and basic aspects.
    Majzoub JA; Srivatsa A
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():60-5. PubMed ID: 17261971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium-induced nephrogenic diabetes insipidus.
    Eustatia-Rutten CF; Tamsma JT; Meinders AE
    Neth J Med; 2001 Mar; 58(3):137-42. PubMed ID: 11246113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-lithium-induced renal failure with secondary lithium toxicity: case reports.
    Stern TA; Brotman AW
    J Clin Psychiatry; 1985 Jan; 46(1):26-8. PubMed ID: 3917429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.